Table 3 Responses to the survey shown in Table 1 (n=33)
Questions | Yes | |
|---|---|---|
Is Ki-67 proliferative index useful for therapy? | 100% | |
Is Ki-67 proliferative index useful for prognosis? | 81.8% | |
What Ki-67 cut-off is a “poor prognostic feature”? | ||
5% | 3.0% | |
10% | 6.1% | |
>10% | 90.9% | |
Does variability in NEN terminology affect practice? | 63.6% | |
Is it important to determine low-grade NEN site of origin in patients with metastatic lesions | 78.8% | |
